Ishizumi H, Yamamoto T: Impairment of N-methyl-D-aspartate receptor-controlled motor activity in
Ishizumi H, Yamamoto T: Impairment of N-methyl-D-aspartate receptor-controlled motor activity in LYN-deficient mice. Neuroscience 2003, 118:709?13. 37. Goldenberg-Furmanov M, Stein I, Pikarsky E, Rubin H, Kasem S, Wygoda M, Weinstein I, Reuveni H, Ben-Sasson SA: Lyn is a target gene for prostate cancer: Sequence-based inhibition induces regression of human tumor xenografts. Cancer Res 2004, 64:1058?066. 38. Verhagen AM, Wallace ME, Goradia A, Jones SA, Croom HA, Metcalf D, Collinge JE, HIV-1 integrase inhibitor 2 cost Maxwell MJ, Hibbs ML, Alexander WS, et al: A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency. J Immunol 2009, 182:2020?029. 39. Barouch-Bentov R, Che J, Lee CC, Yang Y, Herman A, Jia Y, Velentza A, Watson J, Sternberg L, Kim S, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28380356 et al: A conserved salt bridge in the G loop of multiple protein kinases is important for catalysis and for in vivo Lyn function. Mol Cell 2009, 33:43?2. 40. Karur VG, Lowell CA, Besmer P, Agosti V, Wojchowski DM: Lyn kinase promotes erythroblast expansion and late-stage development. Blood 2006, 108:1524?532. 41. De Franceschi L, Fumagalli L, Olivieri O, Corrocher R, Lowell CA, Berton G: Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport. J Clin Invest 1997, 99:220?27. 42. Brunati AM, Bordin L, Clari G, James P, Quadroni M, Baritono E, Pinna LA, Donella-Deana A: Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood 2000, 96:1550?557. 43. Maccaglia A, Mallozzi C, Minetti M: Differential effects of quercetin and resveratrol on Band 3 tyrosine phosphorylation signalling of red blood cells. Biochem Biophys Res Comm 2003, 305:541?47. 44. Santini V, Scappini B, Grossi A, Gozzini A, Bonsi L, Pagliai G, Ferrini PR, Bagnara GP: Lyn kinase is activated following thrombopoietin stimulation of the megakaryocytic cell line B1647. Haematologica 2002, 87:1242?247. 45. Brunati AM, Deana R, Folda A, Massimino ML, Marin O, Ledro S, Pinna LA, Donella-Deana A: Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the protein. J Biol Chem 2005, 280:21029?1035. 46. Hirao A, Hamaguchi I, Suda T, Yamaguchi N: Translocation of the csk homologous kinase (chk/hyl) controls activity of cd36-anchored lyn tyrosine kinase in thrombin-stimulated platelets. EMBO J 1997, 16:2342?351. 47. Maxwell MJ, Yuan Y, Anderson KE, Hibbs ML, Salem HH, Jackson SP: SHIP1 and Lyn Kinase Negatively Regulate Integrin alpha IIb beta 3 signaling in platelets. J Biol Chem 2004, 279:32196?2204. 48. Quek LS, Pasquet JM, Hers I, Cornall R, Knight G, Barnes M, Hibbs ML, Dunn AR, Lowell CA, Watson SP: Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood 2000, 96:4246?253. 49. Kawakami Y, Kitaura J, Satterthwaite AB, Kato RM, Asai K, Hartman SE, Maeda-Yamamoto M, Lowell CA, Rawlings DJ, Witte ON, Kawakami T: Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J Immunol 2000, 165:1210?219.50. Odom S, Gomez G, Kovarova M, Furumoto Y, Ryan JJ, Wright HV, Gonzalez-Espinosa C, Hibbs ML, Harder KW, Rivera J: Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med 2004, 199:1491?502. 51.
